1. Home
  2. ELTX vs FBIO Comparison

ELTX vs FBIO Comparison

Compare ELTX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.10

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.41

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
FBIO
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
113.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELTX
FBIO
Price
$8.10
$3.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$13.00
$16.50
AVG Volume (30 Days)
80.7K
1.2M
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$62,303,000.00
Revenue This Year
N/A
$29.71
Revenue Next Year
N/A
$49.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.60
$1.33
52 Week High
$12.62
$4.53

Technical Indicators

Market Signals
Indicator
ELTX
FBIO
Relative Strength Index (RSI) 49.58 45.34
Support Level $7.81 $3.33
Resistance Level $8.23 $3.60
Average True Range (ATR) 0.49 0.32
MACD 0.03 -0.11
Stochastic Oscillator 39.47 12.11

Price Performance

Historical Comparison
ELTX
FBIO

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: